We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

112 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $2.41M | Put options by funds: $1.19M

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

2.21% more ownership

Funds ownership: 33.22% → 35.44% (+2.2%)

1% more funds holding

Funds holding: 111 → 112 (+1)

1% less capital invested

Capital invested by funds: $125M → $123M (-$1.86M)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

Holders
112
Holders Change
+1
Holders Change %
+0.9%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
16
Increased
21
Reduced
25
Closed
12
Calls
$2.41M
Puts
$1.19M
Net Calls
+$1.22M
Net Calls Change
+$2.75M

Top Buyers

Rank Fund Capital Flow
1
AA
Ascent Advisors
Minnesota
+$11.5M
2
Bank of America
Bank of America
North Carolina
+$3.93M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.83M
4
CCA
Conservest Capital Advisors
Pennsylvania
+$729K
5
Wells Fargo
Wells Fargo
California
+$667K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.03M
2
Corient Private Wealth
Corient Private Wealth
Florida
-$1.9M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.1M
4
LPL Financial
LPL Financial
California
-$1.01M
5
UBS Group
UBS Group
Switzerland
-$690K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
101
IFP Advisors
Florida
$7.52K +$7.71K +40 New
MEG
102
Millstone Evans Group
Colorado
$6.96K – – –
NA
103
NewEdge Advisors
Louisiana
$6.92K -$385 -2 -5%
CPA
104
Cardiff Park Advisors
California
$6.58K – – –
AF
105
Advisornet Financial
Minnesota
$6.05K – – –
SIS
106
Sound Income Strategies
Florida
$5.3K – – –
PP
107
Pacifica Partners
Canada
$4.7K – – –
Qube Research & Technologies (QRT)
108
Qube Research & Technologies (QRT)
United Kingdom
$4.51K – – –
AIP
109
Ameritas Investment Partners
Nebraska
$3.76K – – –
AWM
110
AE Wealth Management
Kansas
$2.07K – – –
TCM
111
Triumph Capital Management
Colorado
$1.5K – – –
WP
112
WealthShield Partners
North Carolina
$1.32K +$1.35K +7 New
DWM
113
Darwin Wealth Management
Florida
$940 +$963 +5 New
GCP
114
GSA Capital Partners
United Kingdom
– -$423K -2,234 Closed
Wealth Enhancement Advisory Services
115
Wealth Enhancement Advisory Services
Minnesota
– -$401K -2,060 Closed
MML Investors Services
116
MML Investors Services
Massachusetts
– -$384K -2,027 Closed
Envestnet Asset Management
117
Envestnet Asset Management
Illinois
– -$334K -1,763 Closed
SFS
118
Strategic Financial Services
New York
– -$266K -1,334 Closed
CA
119
Continuum Advisory
Idaho
– -$239K -1,262 Closed
Jane Street
120
Jane Street
New York
– -$227K -1,200 Closed
Northern Trust
121
Northern Trust
Illinois
– -$208K -1,100 Closed
Simplex Trading
122
Simplex Trading
Illinois
– -$23.7K -125 Closed
RFP
123
Root Financial Partners
California
– -$18.9K -100 Closed
IAIM
124
International Assets Investment Management
Florida
– -$2.14K -11 Closed
KFAS
125
Keating Financial Advisory Services
Kansas
– -$1.51K -8 Closed
1 2 3 4
5

BBH Hedge Fund Activity: Q1 2026 in Review

112 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2026, worth a combined $123M — down 1.5% from $125M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 12 closed out — a net gain of 4 holders — while 21 added to existing stakes and 25 trimmed.

The largest buyer was Ascent Advisors, opening a new position worth an estimated $11.5M. The largest seller was Morgan Stanley, cutting an estimated $5.03M.

  • 112 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2026, up from 111 in Q4 2025.
  • Funds reported $123M of VanEck Biotech ETF stock for Q1 2026, down 1.5% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q1 2026 and 12 closed out, a net change of +4 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2026 was Ascent Advisors, an estimated $11.5M added.
  • The largest VanEck Biotech ETF seller in Q1 2026 was Morgan Stanley, an estimated $5.03M sold.

Based on aggregated 13F filings for Q1 2026.